Processa Pharmaceuticals, Inc. Increase (Decrease) in Prepaid Expenses, Other
Processa Pharmaceuticals, Inc. (PCSA) reported Increase (Decrease) in Prepaid Expenses, Other of $47.72 thousand for the 3-month period ending 2017-03-31, per its 10-Q filed 2017-10-04.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpensesOther · last filed 2017-11-20
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2017-03-31 was $47.72K, a 2.73% increase year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for the quarter ending 2016-06-30 was $1.27K, a 73.06% decline year-over-year.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2016 was $47.72K, a 54.61% decline from fiscal 2015.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2015 was $105.14K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2014 was -$27.47K.
- Processa Pharmaceuticals, Inc. increase (decrease) in prepaid expenses, other for fiscal 2013 was -$24.52K.
| Period end | Increase (Decrease) in Prepaid Expenses, Other 3 month | Increase (Decrease) in Prepaid Expenses, Other 3 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 6 month | Increase (Decrease) in Prepaid Expenses, Other 6 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 9 month | Increase (Decrease) in Prepaid Expenses, Other 9 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 12 month | Increase (Decrease) in Prepaid Expenses, Other 12 month as first filed | Increase (Decrease) in Prepaid Expenses, Other 33 month | Increase (Decrease) in Prepaid Expenses, Other 36 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-03-31 | $47.72K 10-Q · filed 2017-10-04 | $47.72K derived: sum of 2 quarters · filed 2017-10-04 | $47.72K derived: sum of 3 quarters · filed 2017-11-20 | $48.99K derived: sum of 4 quarters · filed 2017-11-20 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $0.00 derived: sum of 2 quarters · filed 2017-11-20 | $1.27K derived: sum of 3 quarters · filed 2017-11-20 | $47.72K 10-K · filed 2017-09-25 | ||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-20 | $1.27K derived: sum of 2 quarters · filed 2017-11-20 | $47.72K 10-Q · filed 2017-11-20 | $50.27K derived: sum of 4 quarters · filed 2017-11-20 | ||||||
| 2016-06-30 | $1.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-10-04 | $47.72K 10-Q · filed 2017-10-04 | $50.27K derived: sum of 3 quarters · filed 2017-10-04 | $64.25K derived: sum of 4 quarters · filed 2017-10-04 | ||||||
| 2016-03-31 | $46.45K 10-Q · filed 2017-10-04 | $49.01K derived: sum of 2 quarters · filed 2017-10-04 | $62.98K derived: sum of 3 quarters · filed 2017-10-04 | $67.69K derived: sum of 4 quarters · filed 2017-10-04 | ||||||
| 2015-12-31 | $2.55K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $16.53K derived: sum of 2 quarters · filed 2017-09-25 | $21.24K derived: sum of 3 quarters · filed 2017-09-25 | $105.14K 10-K · filed 2017-09-25 | ||||||
| 2015-09-30 | $13.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $18.68K derived: sum of 2 quarters · filed 2017-09-08 | $102.58K 10-Q · filed 2017-09-08 | $125.89K 10-Q · filed 2015-12-01 | $87.58K derived: sum of 4 quarters · filed 2017-09-08 | |||||
| 2015-06-30 | $4.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-30 | $88.61K 10-Q · filed 2017-08-30 | $99.36K 10-Q · filed 2015-08-19 | $73.61K derived: sum of 3 quarters · filed 2017-08-30 | $77.08K derived: sum of 4 quarters · filed 2017-08-30 | |||||
| 2015-03-31 | $83.90K 10-Q · filed 2017-08-07 | $89.43K 10-Q · filed 2015-05-15 | $68.90K derived: sum of 2 quarters · filed 2017-08-07 | $72.37K derived: sum of 3 quarters · filed 2017-08-07 | $63.48K derived: sum of 4 quarters · filed 2017-08-07 | |||||
| 2014-12-31 | -$15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | -$11.53K derived: sum of 2 quarters · filed 2017-06-19 | -$20.42K derived: sum of 3 quarters · filed 2017-06-19 | -$27.47K 10-K · filed 2017-06-19 | -$26.98K 10-K · filed 2015-04-14 | |||||
| 2014-09-30 | $3.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-12-01 | -$5.41K derived: sum of 2 quarters · filed 2015-12-01 | -$12.47K 10-Q · filed 2015-12-01 | -$6.76K derived: sum of 4 quarters · filed 2015-12-01 | ||||||
| 2014-06-30 | -$8.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-19 | -$15.94K 10-Q · filed 2015-08-19 | -$10.24K derived: sum of 3 quarters · filed 2015-08-19 | -$41.87K derived: sum of 4 quarters · filed 2015-08-19 | ||||||
| 2014-03-31 | -$7.06K 10-Q · filed 2015-05-15 | -$1.35K derived: sum of 2 quarters · filed 2015-05-15 | -$32.98K derived: sum of 3 quarters · filed 2015-05-15 | -$31.53K derived: sum of 4 quarters · filed 2015-05-15 | -$87.94K 10-Q · filed 2014-05-14 | |||||
| 2013-12-31 | $5.71K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | -$25.93K derived: sum of 2 quarters · filed 2015-04-14 | -$24.47K derived: sum of 3 quarters · filed 2015-04-14 | -$24.52K 10-K · filed 2015-04-14 | -$80.89K 10-K · filed 2014-03-27 | |||||
| 2013-09-30 | -$31.63K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$30.18K derived: sum of 2 quarters · filed 2014-11-13 | -$30.22K 10-Q · filed 2014-11-13 | |||||||
| 2013-06-30 | $1.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-19 | $1.41K 10-Q · filed 2014-08-19 | ||||||||
| 2013-03-31 | -$48.00 10-Q · filed 2014-05-14 | |||||||||
| 2012-12-31 | -$56.37K 10-K · filed 2014-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |